Search research articles
Contact Us
Filters
Showing results (91-100 of 98) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 98 results.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 15, 2014
Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011
M J Dautzenberg, J M Ossewaarde, M E de Kraker, et al.
International Journal of Cardiology
|
July 27, 2015
Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis
M R Hazebroek, M J Kemna, S Schalla, et al.
AIDS (London, England)
|
June 5, 1999
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)
J W Cohen Stuart, R Schuurman, D M Burger, et al.
Current Neurovascular Research
|
April 10, 2009
Haptoglobin phenotype may alter endothelial progenitor cell cluster formation in cerebral small vessel disease
R P W Rouhl, R J van Oostenbrugge, J G M C Damoiseaux, et al.
AIDS (London, England)
|
December 2, 1998
Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infections
J W Cohen Stuart, W A Slieker, G T Rijkers, et al.
Immunologic Research
|
November 15, 2014
Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I
A Artenjak, I Locatelli, H Brelih, et al.
Nature Medicine
|
September 6, 2000
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection
M D Hazenberg, S A Otto, J W Cohen Stuart, et al.
Neurology
|
November 7, 2008
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy
O Stüve, P D Cravens, E M Frohman, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 98) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 98 results.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 15, 2014
Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011
M J Dautzenberg, J M Ossewaarde, M E de Kraker, et al.
International Journal of Cardiology
|
July 27, 2015
Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis
M R Hazebroek, M J Kemna, S Schalla, et al.
AIDS (London, England)
|
June 5, 1999
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)
J W Cohen Stuart, R Schuurman, D M Burger, et al.
Current Neurovascular Research
|
April 10, 2009
Haptoglobin phenotype may alter endothelial progenitor cell cluster formation in cerebral small vessel disease
R P W Rouhl, R J van Oostenbrugge, J G M C Damoiseaux, et al.
AIDS (London, England)
|
December 2, 1998
Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infections
J W Cohen Stuart, W A Slieker, G T Rijkers, et al.
Immunologic Research
|
November 15, 2014
Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I
A Artenjak, I Locatelli, H Brelih, et al.
Nature Medicine
|
September 6, 2000
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection
M D Hazenberg, S A Otto, J W Cohen Stuart, et al.
Neurology
|
November 7, 2008
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy
O Stüve, P D Cravens, E M Frohman, et al.
Page
of 10